| [1] | K. Levada, N. Guldiken, X. Zhang, G. Vella, F. Mo, L. P. James, J. Haybaeck, S. M. Kessler, A. K. Kiemer, T. Ott, D. Hartmann, N. Hüser, M. Ziol, C. Trautwein, P. Strnad,
"Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling", J. Hepatol., vol. 68, no. 5, pp. 996–1005.
|
| [2] | K. Hamesch, N. Guldiken, M. Aly, N. Hüser, D. Hartmann, P. Rufat, M. Ziol, K. Remih, G. Lurje, B. Scheiner, C. Trautwein, M. Mandorfer, T. Reiberger, S. Mueller, T. Bruns, P. Nahon, P. Strnad,
"Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases", BMC Med., vol. 18, no. 1, pp. 336.
|
| [3] | K. Hamesch, M. Mandorfer, V. M. Pereira, L. S. Moeller, M. Pons, G. E. Dolman, M. C. Reichert, C. V. Schneider, V. Woditsch, J. Voss, C. Lindhauer, M. Fromme, I. Spivak, N. Guldiken, B. Zhou, A. Arslanow, B. Schaefer, H. Zoller, E. Aigner, T. Reiberger, M. Wetzel, B. Siegmund, C. Simões, R. Gaspar, L. Maia, D. Costa, M. Bento-Miranda, J. van Helden, E. Yagmur, D. Bzdok, J. Stolk, W. Gleiber, V. Knipel, W. Windisch, R. Mahadeva, R. Bals, R. Koczulla, M. Barrecheguren, M. Miravitlles, S. Janciauskiene, F. Stickel, F. Lammert, R. Liberal, J. Genesca, W. J. Griffiths, M. Trauner, A. Krag, C. Trautwein, P. Strnad,
"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi*ZZ mutation", Gastroenterology, vol. 157, no. 3, pp. 705–719.e18.
|
| [4] | N. Guldiken, V. Usachov, K. Levada, C. Trautwein, M. Ziol, P. Nahon, P. Strnad,
"Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease", Liver Int., vol. 35, no. 4, pp. 1203–1212.
|
| [5] | N. Guldiken, J. Argemi, B. Gurbuz, S. R. Atkinson, M. Oliverius, P. Fila, K. Hamesch, T. Bruns, J. Cabezas, J. J. Lozano, J. Mann, S. Cao, P. Mathurin, V. H. Shah, C. Trautwein, M. R. Thursz, R. Bataller, P. Strnad,
"Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases", BMC Med., vol. 19, no. 1, pp. 39.
|
| [6] | N. Guldiken, K. Hamesch, S. . . . . . . . . . . . . . . . . . . . M. Schuller, M. Aly, C. Lindhauer, C. V. Schneider, M. Fromme, C. Trautwein, P. Strnad,
"Mild iron overload as seen in individuals homozygous for the alpha-1 antitrypsin Pi*Z variant does not promote liver fibrogenesis in HFE knockout mice", Cells, vol. 8, no. 11, pp. 1415.
|
| [7] | A. Gross, L. A. P. Pack, G. . . . . . . . . . . . . . . . . . . . M. Schacht, S. Kant, H. Ungewiss, M. Meir, N. Schlegel, C. Preisinger, P. Boor, N. Guldiken, C. . . . . . . . . . . . . . . . . . . . A. Krusche, G. Sellge, C. Trautwein, J. Waschke, A. Heuser, R. E. Leube, P. Strnad,
"Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury", Mucosal Immunol., vol. 11, no. 6, pp. 1630–1639.
|
| [8] | N. Guldiken, G. Kobazi Ensari, P. Lahiri, G. Couchy, C. Preisinger, C. Liedtke, H. W. Zimmermann, M. Ziol, P. Boor, J. Zucman-Rossi, C. Trautwein, P. Strnad,
"Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease", J. Hepatol., vol. 65, no. 3, pp. 552–559.
|
| [9] | N. Guldiken, Q. Zhou, O. Kucukoglu, M. Rehm, K. Levada, A. Gross, R. Kwan, L. P. James, C. Trautwein, M. B. Omary, P. Strnad,
"Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation", Hepatology, vol. 62, no. 3, pp. 876–886.
|
| [10] | Y. Chen, N. Guldiken, M. Spurny, H. H. Mohammed, J. Haybaeck, M. J. Pollheimer, P. Fickert, N. Gassler, M. K. Jeon, C. Trautwein, P. Strnad,
"Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction", J. Pathol., vol. 237, no. 3, pp. 343–354.
|